当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 现金流量表

特宝生物

(688278)

  

流通市值:291.63亿  总市值:291.63亿
流通股本:4.07亿   总股本:4.07亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,454,222,650.871,609,290,713.9806,382,960.162,542,432,982.68
  收到的税费返还1,053,779.861.4-813,528.94
  收到其他与经营活动有关的现金30,954,046.7520,440,741.7814,936,533.532,116,332.11
  经营活动现金流入小计2,486,230,477.481,629,731,457.08821,319,493.662,575,362,843.73
  购买商品、接受劳务支付的现金186,343,062.4188,983,339.7737,915,914.43152,996,440.57
  支付给职工以及为职工支付的现金686,802,192.98450,478,475.84251,792,654.35739,657,133.79
  支付的各项税费191,176,718.99142,204,355.1871,759,296.32229,631,677.74
  支付其他与经营活动有关的现金950,790,296.4587,519,873.82253,111,450.761,022,444,413.21
  经营活动现金流出小计2,015,112,270.781,269,186,044.61614,579,315.862,144,729,665.31
  经营活动产生的现金流量净额471,118,206.7360,545,412.47206,740,177.8430,633,178.42
二、投资活动产生的现金流量:
  收回投资收到的现金1,047,638,167.17846,874,667.36581,340,103.53639,120,894.38
  处置固定资产、无形资产和其他长期资产收回的现金净额21,90021,30014,00027,809.32
  投资活动现金流入小计1,047,660,067.17846,895,967.36581,354,103.53639,148,703.7
  购建固定资产、无形资产和其他长期资产支付的现金168,636,047.1998,678,266.4459,717,400.69251,353,307.5
  投资支付的现金1,178,394,721.08695,000,000570,000,000696,412,200
  投资活动现金流出小计1,347,030,768.27793,678,266.44629,717,400.69947,765,507.5
  投资活动产生的现金流量净额-299,370,701.153,217,700.92-48,363,297.16-308,616,803.8
三、筹资活动产生的现金流量:
  吸收投资收到的现金54,439,826.4---
  取得借款收到的现金120,000,00010,000,00010,000,000-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计174,439,826.410,000,00010,000,000-
  分配股利、利润或偿付利息支付的现金252,387,208.33252,362,208.33146,208.33166,788,000
  支付其他与筹资活动有关的现金5,970,558.544,420,102.392,044,881.96,228,998.14
  筹资活动现金流出小计258,357,766.87256,782,310.722,191,090.23173,016,998.14
  筹资活动产生的现金流量净额-83,917,940.47-246,782,310.727,808,909.77-173,016,998.14
四、汇率变动对现金及现金等价物的影响-201,057.26170,763.6364,915.87-134,623.31
五、现金及现金等价物净增加额87,628,507.87167,151,566.3166,250,706.28-51,135,246.83
  加:期初现金及现金等价物余额361,515,698.43361,515,698.43361,515,698.43412,650,945.26
  期末现金及现金等价物余额449,144,206.3528,667,264.73527,766,404.71361,515,698.43
补充资料:
  净利润-427,894,111.21-827,602,233.89
  固定资产和投资性房地产折旧-23,156,309.38-32,993,731.87
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,156,309.38-32,993,731.87
  无形资产摊销-20,423,225.35-36,036,331.97
  长期待摊费用摊销-6,166,068.79-18,082,042.93
  处置固定资产、无形资产和其他长期资产的损失--21,300--65,368.15
  固定资产报废损失-242,604.15-92,286.92
  公允价值变动损失--590,535.23--882,868.15
  财务费用-209,203.06-587,305.32
  投资损失--1,873,297.19--4,053,394.38
  递延所得税--3,070,583.72--24,899,123.74
  其中:递延所得税资产减少--3,121,936.16--25,427,873.64
    递延所得税负债增加-51,352.44-528,749.9
  存货的减少--57,645,754.59--76,528,701.77
  经营性应收项目的减少-4,504,566.2--404,826,737.45
  经营性应付项目的增加--87,684,247.3-453,232.52
  其他-26,392,458.89-16,100,715.14
  现金的期末余额-528,667,264.73-361,515,698.43
  减:现金的期初余额-361,515,698.43-412,650,945.26
  现金及现金等价物的净增加额-167,151,566.3--51,135,246.83
公告日期2025-10-232025-08-212025-04-232025-03-28
审计意见(境内)标准无保留意见
TOP↑